| | | | | |
ANIK Anika Therapeutics Inc | $21,1860 | -0,35 % | $294,82M | $21,93K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4890 | +0,09 % | $294,73M | $140,00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0400 | +0,00 % | $294,68M | $12,00 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,0490 | -0,07 % | $294,53M | $5,64K | |
| $42,8850 | -1,62 % | $294,35M | $1,32K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0240 | +0,24 % | $294,35M | $178,00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00 % | $294,33M | $168,00 | |
SLN Silence Therapeutics Plc American Depository Share | $13,3700 | -1,76 % | $294,27M | $118,97K | |
MTNE CH4 Natural Solutions Corporation | $9,8940 | +0,04 % | $293,88M | $6,000 | |
RXST RxSight, Inc. Common Stock | $6,1150 | -0,73 % | $293,64M | $169,65K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6300 | -0,05 % | $293,52M | $402,67K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,00 % | $293,49M | $300,00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9,4150 | +5,08 % | $293,27M | $85,58K | |
| $10,1100 | -2,13 % | $292,98M | $221,77K | |
JCE Nuveen Core Equity Alpha Fund | $16,9780 | +0,08 % | $292,78M | $5,61K | |
